Trinity Biotech Current Ratio 2010-2023 | TRIB
Trinity Biotech current ratio from 2010 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Trinity Biotech Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2023-09-30 | $0.04B | $0.01B | 3.44 |
| 2023-06-30 | $0.05B | $0.02B | 3.59 |
| 2023-03-31 | $0.06B | $0.02B | 3.61 |
| 2022-12-31 | $0.05B | $0.02B | 2.69 |
| 2022-09-30 | $0.05B | $0.02B | 3.38 |
| 2022-06-30 | $0.06B | $0.01B | 4.12 |
| 2022-03-31 | $0.06B | $0.02B | 3.66 |
| 2021-12-31 | $0.07B | $0.10B | 0.72 |
| 2021-09-30 | $0.08B | $0.10B | 0.76 |
| 2021-06-30 | $0.08B | $0.11B | 0.77 |
| 2021-03-31 | $0.09B | $0.03B | 2.77 |
| 2020-12-31 | $0.08B | $0.03B | 3.08 |
| 2020-09-30 | $0.07B | $0.02B | 3.13 |
| 2020-06-30 | $0.07B | $0.02B | 2.89 |
| 2020-03-31 | $0.07B | $0.02B | 3.06 |
| 2019-12-31 | $0.07B | $0.02B | 3.67 |
| 2019-09-30 | $0.08B | $0.03B | 3.13 |
| 2019-06-30 | $0.08B | $0.02B | 3.36 |
| 2019-03-31 | $0.09B | $0.02B | 4.30 |
| 2018-12-31 | $0.09B | $0.02B | 4.92 |
| 2018-09-30 | $0.09B | $0.02B | 4.48 |
| 2018-06-30 | $0.11B | $0.02B | 5.23 |
| 2018-03-31 | $0.11B | $0.02B | 5.03 |
| 2017-12-31 | $0.11B | $0.02B | 5.30 |
| 2017-09-30 | $0.12B | $0.02B | 5.16 |
| 2017-06-30 | $0.12B | $0.02B | 5.32 |
| 2017-03-31 | $0.13B | $0.02B | 5.98 |
| 2016-12-31 | $0.13B | $0.03B | 5.28 |
| 2016-09-30 | $0.15B | $0.02B | 7.27 |
| 2016-06-30 | $0.15B | $0.02B | 7.59 |
| 2016-03-31 | $0.16B | $0.02B | 7.86 |
| 2015-12-31 | $0.16B | $0.02B | 8.10 |
| 2015-09-30 | $0.17B | $0.02B | 8.54 |
| 2015-06-30 | $0.18B | $0.02B | 8.71 |
| 2015-03-31 | $0.07B | $0.02B | 3.42 |
| 2014-12-31 | $0.07B | $0.02B | 3.13 |
| 2014-09-30 | $0.07B | $0.02B | 4.31 |
| 2014-06-30 | $0.08B | $0.02B | 4.39 |
| 2014-03-31 | $0.07B | $0.02B | 4.33 |
| 2013-12-31 | $0.08B | $0.02B | 3.66 |
| 2013-09-30 | $0.08B | $0.02B | 3.37 |
| 2013-06-30 | $0.11B | $0.02B | 7.31 |
| 2013-03-31 | $0.11B | $0.01B | 7.84 |
| 2012-12-31 | $0.11B | $0.01B | 8.53 |
| 2012-09-30 | $0.11B | $0.01B | 8.04 |
| 2012-06-30 | $0.11B | $0.01B | 8.09 |
| 2012-03-31 | $0.11B | $0.01B | 9.15 |
| 2011-12-31 | $0.12B | $0.01B | 8.63 |
| 2011-09-30 | $0.11B | $0.01B | 9.17 |
| 2011-06-30 | $0.11B | $0.01B | 8.70 |
| 2011-03-31 | $0.10B | $0.01B | 7.44 |
| 2010-12-31 | $0.10B | $0.01B | 8.27 |
| 2010-09-30 | $0.10B | $0.01B | 7.36 |
| 2010-06-30 | $0.10B | $0.01B | 7.41 |
| 2010-03-31 | $0.07B | $0.03B | 2.61 |
| 2009-12-31 | $0.07B | $0.03B | 2.67 |
| 2009-09-30 | $0.07B | $0.03B | 2.30 |
| 2009-06-30 | $0.08B | $0.03B | 2.24 |
| 2009-03-31 | $0.07B | $0.03B | 2.14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.014B | $0.057B |
| Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.663B | 23.98 |
| Stryker (SYK) | United States | $124.585B | 30.89 |
| Medtronic (MDT) | Ireland | $105.150B | 14.89 |
| Boston Scientific (BSX) | United States | $98.912B | 32.89 |
| EssilorLuxottica (ESLOY) | France | $98.803B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.442B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.123B | 29.04 |
| ResMed (RMD) | United States | $26.124B | 26.12 |
| Terumo (TRUMY) | Japan | $24.607B | 34.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.518B | 15.78 |
| Baxter (BAX) | United States | $20.135B | 14.69 |
| Koninklijke Philips (PHG) | Netherlands | $18.554B | 14.80 |
| Insulet (PODD) | United States | $11.535B | 60.56 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.496B | 0.00 |
| Demant (WILYY) | Denmark | $9.782B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.014B | 23.88 |
| BellRing Brands (BRBR) | United States | $7.103B | 38.19 |
| Lantheus Holdings (LNTH) | United States | $4.273B | 11.03 |
| Haemonetics (HAE) | United States | $4.239B | 21.68 |
| Perrigo (PRGO) | Ireland | $4.057B | 11.60 |
| GN Store Nord (GNNDY) | Denmark | $3.581B | 23.19 |
| Envista Holdings (NVST) | United States | $3.394B | 12.91 |
| Prestige Consumer Healthcare (PBH) | United States | $3.394B | 16.05 |
| Green Thumb Industries (GTBIF) | United States | $2.720B | 86.20 |
| Neogen (NEOG) | United States | $2.584B | 24.85 |
| QuidelOrtho (QDEL) | United States | $2.559B | 9.29 |
| ICU Medical (ICUI) | United States | $2.361B | 17.62 |
| TG Therapeutics (TGTX) | United States | $2.160B | 699.50 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.913B | 0.00 |
| Owens & Minor (OMI) | United States | $1.843B | 17.69 |
| Verano Holdings (VRNOF) | United States | $1.841B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.654B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.466B | 45.66 |
| InMode (INMD) | Israel | $1.456B | 7.54 |
| LeMaitre Vascular (LMAT) | United States | $1.406B | 46.38 |
| AdaptHealth (AHCO) | United States | $1.244B | 9.36 |
| Warby Parker (WRBY) | United States | $1.169B | 0.00 |
| AtriCure (ATRC) | United States | $1.131B | 0.00 |
| MacroGenics (MGNX) | United States | $1.005B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.726B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.718B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.713B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.687B | 14.84 |
| Evolus (EOLS) | United States | $0.670B | 0.00 |
| Jin Medical (ZJYL) | China | $0.617B | 0.00 |
| Quanterix (QTRX) | United States | $0.604B | 0.00 |
| Valneva SE (VALN) | France | $0.565B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.528B | 11.44 |
| TerrAscend (TSNDF) | Canada | $0.507B | 0.00 |
| PetIQ (PETQ) | United States | $0.472B | 17.61 |
| ZimVie (ZIMV) | United States | $0.427B | 26.13 |
| Biote (BTMD) | United States | $0.405B | 3.86 |
| OraSure Technologies (OSUR) | United States | $0.402B | 6.65 |
| Surmodics (SRDX) | United States | $0.376B | 40.60 |
| Zynex (ZYXI) | United States | $0.368B | 42.41 |
| Aurora Cannabis (ACB) | Canada | $0.356B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.302B | 30.00 |
| Cerus (CERS) | United States | $0.297B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.293B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.259B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.241B | 14.71 |
| Veru (VERU) | United States | $0.208B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.193B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.189B | 0.00 |
| Omeros (OMER) | United States | $0.186B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.159B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 21.55 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.131B | 66.00 |
| InterCure (INCR) | Israel | $0.118B | 19.92 |
| Fonar (FONR) | United States | $0.106B | 9.14 |
| MariMed (MRMD) | United States | $0.104B | 0.00 |
| Safety Shot (SHOT) | United States | $0.099B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Chimerix (CMRX) | United States | $0.083B | 0.00 |
| Brainsway (BWAY) | Israel | $0.080B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.069B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.058B | 3.80 |
| Apyx Medical (APYX) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.04 |
| Exagen (XGN) | United States | $0.025B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 73.18 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |